Raquel Hladun Alvaro

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders

Vall Hebron Institut de Recerca

Raquel Hladun Alvaro

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders

Vall Hebron Institut de Recerca

Projects

Ensayo clínico Fase I/II para evaluar la seguridad y eficacia de la movilización y colecta de células CD34+ tras tratamiento con plerixafor y filgrastim en pacientes con Anemia de Fanconi para su posterior uso en ensayos de terapia génica

IP: Maria Cristina Díaz de Heredia Rubio
Collaborators: Josep Sánchez de Toledo Codina, Raquel Hladun Alvaro
Funding agency: Ministerio Sanidad
Funding: 437580
Reference: EC11-559
Duration: 01/01/2012 - 30/06/2018

Related news

Dr. Gabriela Guillén receives the award for best presentation at SECP

"Generation of a bank of surgical orthotopic PDX (patient-derived xenografts) models within the framework of a personalized medicine program in pediatric cancer" was the awarded work, of the Childhood Cancer and Hematological Diseases Group of VHIR.

Biomarkers gain prominence in paediatric cancer clinical trials

A study, co-led by Vall d’Hebron, has analysed the evolution of clinical trials with children and adolescents with cancer over the last 15 years, with the aim of optimising efficacy and defining lines for further progress.